Aktis Oncology is a United States biotechnology company focused on developing targeted radiopharmaceutical therapies for solid tumors. Its work centers on linking tumor-targeting molecules with radioisotopes to deliver radiation to cancer cells.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!